Entry |
|
Symbol |
NFKBIA
|
Name |
NF-kappa-B inhibitor alpha
|
Pathway |
map04620 | Toll-like receptor signaling pathway |
map04621 | NOD-like receptor signaling pathway |
map04622 | RIG-I-like receptor signaling pathway |
map04625 | C-type lectin receptor signaling pathway |
map04658 | Th1 and Th2 cell differentiation |
map04660 | T cell receptor signaling pathway |
map04662 | B cell receptor signaling pathway |
map04920 | Adipocytokine signaling pathway |
map05120 | Epithelial cell signaling in Helicobacter pylori infection |
map05130 | Pathogenic Escherichia coli infection |
map05163 | Human cytomegalovirus infection |
map05166 | Human T-cell leukemia virus 1 infection |
map05167 | Kaposi sarcoma-associated herpesvirus infection |
map05168 | Herpes simplex virus 1 infection |
map05170 | Human immunodeficiency virus 1 infection |
map05208 | Chemical carcinogenesis - reactive oxygen species |
map05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Disease |
H00095 | Ectodermal dysplasia associated immunodeficiency |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09130 Environmental Information Processing
09132 Signal transduction
04064 NF-kappa B signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04668 TNF signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04024 cAMP signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04624 Toll and Imd signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04621 NOD-like receptor signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04622 RIG-I-like receptor signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04623 Cytosolic DNA-sensing pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04625 C-type lectin receptor signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04660 T cell receptor signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04658 Th1 and Th2 cell differentiation
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04659 Th17 cell differentiation
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04657 IL-17 signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04662 B cell receptor signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04062 Chemokine signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09152 Endocrine system
04920 Adipocytokine signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04926 Relaxin signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09156 Nervous system
04722 Neurotrophin signaling pathway
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09158 Development and regeneration
04380 Osteoclast differentiation
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05208 Chemical carcinogenesis - reactive oxygen species
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05203 Viral carcinogenesis
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09162 Cancer: specific types
05220 Chronic myeloid leukemia
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05215 Prostate cancer
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05222 Small cell lung cancer
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05170 Human immunodeficiency virus 1 infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05161 Hepatitis B
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05160 Hepatitis C
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05171 Coronavirus disease - COVID-19
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05164 Influenza A
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05162 Measles
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05168 Herpes simplex virus 1 infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05163 Human cytomegalovirus infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05167 Kaposi sarcoma-associated herpesvirus infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05169 Epstein-Barr virus infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09171 Infectious disease: bacterial
05120 Epithelial cell signaling in Helicobacter pylori infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05130 Pathogenic Escherichia coli infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05132 Salmonella infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05131 Shigellosis
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05135 Yersinia infection
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05134 Legionellosis
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09174 Infectious disease: parasitic
05145 Toxoplasmosis
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05140 Leishmaniasis
K04734 NFKBIA; NF-kappa-B inhibitor alpha
05142 Chagas disease
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04931 Insulin resistance
K04734 NFKBIA; NF-kappa-B inhibitor alpha
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors
K04734 NFKBIA; NF-kappa-B inhibitor alpha
04131 Membrane trafficking
K04734 NFKBIA; NF-kappa-B inhibitor alpha
Transcription factors [BR:ko03000]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Ankyrin only
K04734 NFKBIA; NF-kappa-B inhibitor alpha
Membrane trafficking [BR:ko04131]
Autophagy
Chaperone mediated autophagy (CMA)
Selective cargos
K04734 NFKBIA; NF-kappa-B inhibitor alpha
|
Other DBs |
|
Genes |
» show all
|
Reference |
|
Authors |
Spencer E, Jiang J, Chen ZJ |
Title |
Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. |
Journal |
|
Reference |
|
Authors |
Hatakeyama S, Kitagawa M, Nakayama K, Shirane M, Matsumoto M, Hattori K, Higashi H, Nakano H, Okumura K, Onoe K, Good RA, Nakayama K |
Title |
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. |
Journal |
|
Reference |
|
Authors |
Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P, Baldwin AS Jr |
Title |
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. |
Journal |
|
Sequence |
|
LinkDB |
|